Skip to content
Home/Companies/Healthcare/Imcheck
IM

Imcheck

Healthcare·France·Exited 2025·Held 3yr

Imcheck is a healthcare company, headquartered in France.

Entry
2022
Hold
3yr
Exit
2025
Est. EV
–

Who owns Imcheck?

Imcheck was owned by Andera Partners through BioDiscovery 6 (2022 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, Imcheck has been through 3 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 6 · 2022 · VC
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare
Key takeaways
  • ·Held by Kurma Partners since 2020 (6Y hold).
  • ·Average hold across 2 realized cycles: 4 years.

Ownership history

3 ownership periods · co-invest detected

Active
Currently held by Kurma Partners since 2020.
Co-invest · 3 holders · 2020 · present
Eurazeo
EurazeoExited 2025
2020 · 2025 · Kurma Biofund III · 2017 · Healthcare
Trade Sale · to
MOIC
Kurma Partners
Kurma PartnersActive
2020 · present · Kurma Partners Other Investments · Buyout
MOIC
–
Andera Partners
Andera PartnersExited 2025
2022 · 2025 · BioDiscovery 6 · 2022 · VC
Trade Sale · to
MOIC
–

More from BioDiscovery 6

Other portfolio companies in the same fund.

Inventiva
Active
HealthcareFrance· 2024
Kestra Medical Technologies
Active
HealthcareUS· 2024
SciRhom
Active
HealthcareFrance· 2024
Abivax
Active
HealthcareFrance· 2023
Ariceum
Active
HealthcareFrance· 2023
BioVentrix
Active
HealthcareFrance· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings